ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Chungnam National University and SCIEX Accelerate the Realization of “Industry on Campus” with Global Headquarters Alliance

Strategic MOU signed with global mass spectrometry leader SCIEX

SCIEX, a global leader in life science analytical technologies, signed a strategic Memorandum of Understanding (MOU) with Chungnam National University. The agreement, signed by Chris Hagen, President of SCIEX, and Kim Jung-Kyum, President of Chungnam National University, emphasizes the significance of this strategic alliance between the two institutions.

This MOU represents a pivotal first step in realizing Chungnam National University’s “Industry on Campus” vision, which aims to break down the barriers between academia and industry, and foster an innovative ecosystem that integrates education, research, and enterprise. Chungnam National University plans to actively incorporate cutting-edge mass spectrometry technologies from SCIEX into its education and research programs. This could enhance the university’s global competitiveness in precision analysis across key fields such as biotechnology, pharmaceuticals, omics, environment, and food sciences.

SCIEX has led the global life sciences and analytical sciences sectors for over 50 years with high-precision analytical solutions. This collaboration with Chungnam National University is anticipated to:

  • Provide advanced mass spectrometry equipment and technical infrastructure
  • Launch joint research project initiatives
  • Organize seminars and technical workshops
  • Boost cooperation on educational programs

Through this agreement, the two institutions aim to work together to build a collaborative research ecosystem and a global industry-academia cooperation model. This could establish a virtuous cycle that promotes the dissemination of advanced analytical technologies, provides hands-on educational environments, and nurtures next-generation research talent.

The signing ceremony was attended by Jeong Kyoum Kim (President, Chungnam National University), Hyun Joo An (Vice President for International Affairs, Chungnam National University), Chris Hagen (President of SCIEX), and Lawrence Chia (Vice President and GM of SCIEX J-KOSEA), who each share the vision to build a joint research ecosystem based on global-level technological cooperation.

President Kim stated, “This agreement will serve as a practical implementation of Chungnam National University’s Industry on Campus strategy. Through our alliance with SCIEX, we will expand joint research based on advanced analytical technologies and establish an innovation platform that connects education, research, and industry.”

SCIEX President Chris Hagen added, “We hope this collaboration with Chungnam National University marks the beginning of a true strategic alliance to empower the bright minds who will lead the future of science and technology. SCIEX will continue to contribute to the advancement of Korea’s research ecosystem with our global analytical technologies.”

This MOU is expected to contribute to innovation and industrial advancement in the field of analytical science through a sustainable collaboration between a leading national university and a global analytical instrumentation company.

About SCIEX

SCIEX empowers our customers to solve the most impactful analytical challenges in quantitation and characterization. With groundbreaking innovation and outstanding reliability and support, SCIEX has been at the forefront of the field for over 50 years. ​

Since the launch of the first-ever commercially successful triple quadrupole in 1981, we continue to develop technologies and solutions that influence life-changing research and outcomes. That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust. ​

Advances in human wellness depend on the power of precise science.​

For more information, visit sciex.com. ​

Connect with us on LinkedIn, Facebook, and Instagram.​

The SCIEX clinical diagnostic portfolio is for in vitro Diagnostic Use. Rx Only. Product(s) not available in all countries. For information on availability, please contact your local sales representative or refer to www.sciex.com/diagnostics. All other products are For Research Use Only. Not for use in Diagnostic Procedures.

Trademarks and/or registered trademarks mentioned herein, including associated logos, are the property of AB Sciex Pte. Ltd. or their respective owners in the United States and/or certain other countries (see www.sciex.com/trademarks).

© 2025 DH Tech. Dev. Pte. Ltd. MKT- 35606-A.

Chungnam National University and SCIEX accelerate the realization of “Industry on Campus” with Global Headquarters Alliance.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.